Objectives/Hypothesis: Pain is a major cause of morbidity after tonsillecto
my. Although various efforts have been made to reduce pain, the use of oral
analgesics, which can have adverse side effects, remains the standard of c
are. It is hypothesized that fibrin sealant, used to achieve hemostasis and
enhance healing in many surgical procedures, might help decrease pain afte
r this operation. Study Design: A prospective, randomized, blinded study wa
s performed on 20 children aged 5 to 17 years who were undergoing tonsillec
tomy, to evaluate the efficacy of FIBRIN SEALANT in reducing postoperative
pain. Methods: All patients pre-donated 40 mL of blood from which autologou
s concentrated fibrinogen was prepared by cryoprecipitation. In the fibrin
sealant group, fibrinogen and topical bovine thrombin were sprayed onto the
surgical site to form fibrin sealant at the conclusion of tonsillectomy. T
he 10 patients in the control group (C) received no fibrin sealant. Patient
s rated their level of pain immediately after surgery and at regular interv
als for 3 days after surgery using the Wong-Baker Faces Pain Rating Scale (
1-6). Emesis, postoperative bleeding, medications, and adverse events were
also evaluated. Results: At 7:00 P.M. On postoperative day (POD) 0, the mea
n +/-; SD fibrin sealant group pain score (2.9 +/- 0.41 units) was signific
antly lower than for the C group (4.1 +/- 0.43 units; P less than or equal
to .05). There was also a trend in favor of less pain in the fibrin sealant
group at 7:00 P.M. on POD 1, with a mean of 3.5 +/- 0.43 units versus 2.4
+/- 0.48 units for C (P = .15). The odds of a patient in C experiencing eme
sis were 8.16 times higher, (P less than or equal to .05) than for patients
in the fibrin sealant group. Conclusions: Fibrin sealant significantly red
uced pain the evening after pediatric tonsillectomy and also decreased the
chance of experiencing emesis. Thus fibrin sealant may be clinically useful
as an adjunct to tonsillectomy.